NCT03069079

Brief Summary

Title: Investigation of neutrophil defects associated with periodontal disease and tooth loss in children. A clinical study. Objectives: The primary objective of this study is:

  • To investigate presence of periodontal disease and response to periodontal treatment in children affected by neutrophil defects The secondary objectives of this study are:
  • To investigate presence of other dental diseases in children affected by neutrophil defects
  • To assess oral microbiological and inflammatory parameters in children affected by neutrophil defects Primary outcomes: The primary outcomes are (a) presence of periodontal disease as assessed by clinical factors: probing pocket depth, attachment level, bleeding on probing and radiographic bone loss) (b) microbiological and host response factors: detected in periodontal pockets and gingival crevicular fluid and (c) response to treatment Study sample: Children affected by neutrophil defects and meeting outlined inclusion and exclusion criteria Number of participants: 50 children Study design: This is a longitudinal treatment study. All participants will attend for 4-7 visits during the study as outlined below:
  • Screening visit (visit 1): consent procedure, dental examination, saliva and plaque sampling
  • Baseline visit (visit 2):, detailed periodontal examination, dental radiographs, sampling of gingival crevicular fluid and, if appropriate scaling, polishing and oral hygiene instructions
  • Non-surgical periodontal treatment (visit 3A to 3D, max 4 sessions): oral hygiene instructions and supra- and sub-gingival debridement (under local anaesthesia if necessary)
  • Follow-up Visit (visit 4, 4th to 7th visit) (six months following treatment): detailed dental examination, oral hygiene instructions, sampling of saliva, subgingival plaque and gingival crevicular fluid, tooth scaling and polishing.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2016

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2016

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 17, 2017

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 3, 2017

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

November 14, 2022

Status Verified

December 1, 2016

Enrollment Period

2 years

First QC Date

January 17, 2017

Last Update Submit

November 10, 2022

Conditions

Keywords

primary immunodeficiencydental healthneutrophil defectperiodontitis

Outcome Measures

Primary Outcomes (6)

  • Probing pocket depth

    Measurement periodontal pocket depth at baseline (in millimetres, mm)

    At baseline only (0 months)

  • Attachment level

    Measurement of attachment level at baseline (in millimetres, mm)

    At baseline only (0 months)

  • Bleeding on probing

    Proportion of bleeding sites on probing at baseline (in percentage, %)

    At baseline only (0 months)

  • Radiographic bone loss

    Proportion of bone loss in relation to total root length at baseline. (in percentage, %)

    At baseline only (0 months)

  • Microbiological assay

    Microbiological analysis with next generation sequencing of the 16s rRNA metagenome at baseline. (Proportion of specified microbes present in sample at baseline)

    At baseline only (0 months)

  • GCF

    Gingival crevicular fluid inflammatory markers (Proportion specified inflammatory markers present in sample at baseline)

    At baseline only (0 months)

Secondary Outcomes (5)

  • Response to treatment: Probing pocket depth

    From baseline (0 months) to follow-up (24 months)

  • Response to treatment: Attachment level

    From baseline (0 months) to follow-up (24 months)

  • Response to treatment: Bleeding on probing

    From baseline (0 months) to follow-up (24 months)

  • Response to treatment: Microbiological assay

    From baseline (0 months) to follow-up (24 months)

  • Response to treatment: GCF

    From baseline (0 months) to follow-up (24 months)

Study Arms (1)

Non surgical Periodontal therapy

EXPERIMENTAL

All children will be offered an oral hygiene and tooth scaling and polishing session. For children affected by periodontal disease, subgingival debridement will also be performed according to needs, with the aim to disrupt the subgingival biofilm responsible for the onset and progression of the periodontal pathology. This can be accompanied, when appropriate, by the use of local anaesthesia and adjunctive antimicrobials (systemic or locally applied subgingivally), according to the clinical presentation and the child's medical conditions. In addition, when required, nitrous oxide sedation (NOS) could be used before treatment. Caries will be treated as necessary (shared care with the general dental practitioners / community dental services). Children with mucosal lesions requiring treatment will be given a letter for their GDP suggesting referral to a collaborating expert in Oral Medicine (Prof. Stephen Porter).

Procedure: Oral hygiene advice, non surgical periodontal treatment

Interventions

For children affected by periodontal disease, oral hygiene advice, non surgical periodontal treatment will also be performed according to needs. This can be accompanied, when appropriate, by the use of local anaesthesia and adjunctive antimicrobials (systemic or locally applied subgingivally), according to the clinical presentation and the child's medical conditions. Accurate supra- and sub-gingival removal of calculus and dental plaque will be performed both with ultrasonic and/or manual instruments. The necessary sub-gingival debridement will be performed in 1 to 4 visits (either full mouth treatment, half-mouth treatment or quadrant-wise treatment) depending on patient preference and practical considerations, using manual (Gracey curettes, Hu-Friedy) and ultrasonic devices (EMS). .

Non surgical Periodontal therapy

Eligibility Criteria

Age4 Years - 16 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age 4-16 years
  • Diagnosis of one of the following neutrophil defects (as confirmed by the treating physician):
  • Disorders of neutrophil numbers
  • Cyclic neutropenia
  • Congenital neutropenia
  • Severe Congenital Neutropoenia
  • X-linked Neutropoenia
  • Disorders of neutrophil function
  • Leucocyte Adhesion Defect s
  • Other neutrophil disorders/ undefined neutrophil disorders (functional defects demonstrated on testing but genetic basis not yet known)
  • Combined immunodeficiency syndromes
  • Wiskott Aldrich Syndrome
  • Hyper IgM Syndrome
  • Chediak Higashi Syndrome
  • Undefined combined immunodeficiency (functional defects demonstrated on testing but genetic basis not yet known)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Center for Oral Clinical Research, Queen Mary, University of London

London, Greater London, E1 2AD, United Kingdom

Location

Dental and Maxillofacial Department, Great Ormond Street Hospital for Children

London, WC1N 3JH, United Kingdom

Location

MeSH Terms

Conditions

Primary Immunodeficiency DiseasesPeriodontitis

Condition Hierarchy (Ancestors)

Genetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesImmunologic Deficiency SyndromesImmune System DiseasesPeriodontal DiseasesMouth DiseasesStomatognathic Diseases

Study Officials

  • Luigi Nibali, PhD

    Queen Mary University of London

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 17, 2017

First Posted

March 3, 2017

Study Start

December 1, 2016

Primary Completion

December 1, 2018

Study Completion

December 1, 2019

Last Updated

November 14, 2022

Record last verified: 2016-12

Data Sharing

IPD Sharing
Will not share

Locations